A detailed history of Wescap Management Group, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Wescap Management Group, Inc. holds 10,538 shares of PFE stock, worth $289,373. This represents 0.08% of its overall portfolio holdings.

Number of Shares
10,538
Previous 10,724 1.73%
Holding current value
$289,373
Previous $297,000 1.01%
% of portfolio
0.08%
Previous 0.09%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$25.26 - $29.6 $4,698 - $5,505
-186 Reduced 1.73%
10,538 $294,000
Q1 2024

May 13, 2024

BUY
$25.89 - $29.73 $14,394 - $16,529
556 Added 5.47%
10,724 $297,000
Q4 2023

Feb 06, 2024

SELL
$26.13 - $33.94 $381,524 - $495,557
-14,601 Reduced 58.95%
10,168 $292,000
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $132,627 - $155,028
-4,133 Reduced 14.3%
24,769 $821,000
Q2 2023

Aug 10, 2023

SELL
$36.12 - $41.79 $58,297 - $67,449
-1,614 Reduced 5.29%
28,902 $1.06 Million
Q1 2023

May 04, 2023

SELL
$39.39 - $51.28 $127,702 - $166,249
-3,242 Reduced 9.6%
30,516 $1.25 Million
Q4 2022

Feb 10, 2023

SELL
$41.75 - $54.5 $12,984 - $16,949
-311 Reduced 0.91%
33,758 $1.73 Million
Q3 2022

Nov 02, 2022

SELL
$43.76 - $53.42 $21,661 - $26,442
-495 Reduced 1.43%
34,069 $1.49 Million
Q2 2022

Aug 11, 2022

SELL
$46.53 - $55.17 $279,738 - $331,682
-6,012 Reduced 14.82%
34,564 $1.81 Million
Q1 2022

May 11, 2022

SELL
$45.75 - $56.69 $29,005 - $35,941
-634 Reduced 1.54%
40,576 $2.1 Million
Q4 2021

Feb 11, 2022

SELL
$41.32 - $61.25 $43,014 - $63,761
-1,041 Reduced 2.46%
41,210 $2.43 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $57,383 - $73,714
-1,462 Reduced 3.34%
42,251 $1.82 Million
Q2 2021

Aug 02, 2021

BUY
$35.91 - $40.68 $97,495 - $110,446
2,715 Added 6.62%
43,713 $1.59 Million
Q1 2021

May 07, 2021

BUY
$33.49 - $37.77 $1.37 Million - $1.55 Million
40,998 New
40,998 $1.49 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Wescap Management Group, Inc. Portfolio

Follow Wescap Management Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wescap Management Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wescap Management Group, Inc. with notifications on news.